Notably, several randomized controlled trials (RCTs), along with a recent meta-analysis, have demonstrated that GH administration significantly improves endometrial thickness in infertile women with persistently poor endometrial development (often defined as an endometrial lining < 6 mm or a non-trilaminar endometrial pattern) [17,40,41]. The gene discussed is GH1; the disease is Infertility.